RR of MSD remained significant for LOC 2 (1.77; p = 0.009) and LOC 3/4 (1.91; p = 0.015), with a strong trend in RR of SD, but not DMD.
← all excerpts
Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy units.
1
—
—